Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utilizing Clinical Pharmacist Specialist to Manage Hepatitis C Virus Patients on Direct-Acting Antiviral Therapy
Lena A. Mikolas, Kimberly A. Jacques, M Huq, et al.
Journal of Pharmacy Practice (2018) Vol. 32, Iss. 6, pp. 655-663
Closed Access | Times Cited: 15

Showing 15 citing articles:

Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist–Driven Model
David E. Koren, Autumn D. Zuckerman, Robyn Teply, et al.
Open Forum Infectious Diseases (2019) Vol. 6, Iss. 7
Open Access | Times Cited: 29
Hepatitis C virus infection and the role of a pharmaceutical care program
Esther Chamorro‐de‐Vega, Carmen Guadalupe Rodríguez-González, Álvaro Giménez‐Manzorro, et al.
American Journal of Health-System Pharmacy (2019) Vol. 77, Iss. 6, pp. 479-486
Open Access | Times Cited: 12
A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United States
Michelle T. Martin, Aileen N. Pham, Jessica Wagner
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 3, pp. 648-655
Closed Access | Times Cited: 1
Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program
Aziza Ajlan, Roa’a Al-Gain, Mohamed O. Ahmed, et al.
Journal of the American Pharmacists Association (2020) Vol. 61, Iss. 2, pp. e159-e170
Closed Access | Times Cited: 7
Factors that influence patient acceptance of clinical pharmacy services: A nationwide survey
Lauren T. Schumacher, Antoinette B. Coe, Corey A. Lester, et al.
Journal of the American Pharmacists Association (2020) Vol. 60, Iss. 6, pp. 1058-1067.e4
Open Access | Times Cited: 6
Hepatitis C screening in a community pharmacy setting: Patient perspective
Kaitlyn N. Pegump, Robert E. Nichols, Linnea A. Polgreen, et al.
Journal of the American Pharmacists Association (2023) Vol. 63, Iss. 4, pp. S78-S82
Closed Access | Times Cited: 2
Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics
Safiya S Naidjate, Andrew R. Zullo, Ruth Dapaah‐Afriyie, et al.
American Journal of Health-System Pharmacy (2019) Vol. 76, Iss. 10, pp. 646-653
Closed Access | Times Cited: 5
Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
Amber R. Douglass, Ashley J. Maister, Karen E. Moeller, et al.
Mental Health Clinician (2024) Vol. 14, Iss. 4, pp. 253-266
Open Access
A National Survey of Pharmacist Involvement in Hepatitis C Virus Management in the United States
Michelle T. Martin, Allison R. Hietpas, Jožica PETERKA NOVAK, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 12, pp. 890-897
Open Access
Evaluation of a specialty hepatitis C virus telephone pharmacy service
Ashley A. Sabourin, Kaleigh K Fisher-Grant, Adam Saulles, et al.
American Journal of Health-System Pharmacy (2021) Vol. 78, Iss. Supplement_2, pp. S38-S45
Closed Access | Times Cited: 3
Identification and management of contraindicated drug–drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy
Meng‐Hsuan Kuo, Chih‐Wei Tseng, Chi‐Hui Lee, et al.
Journal of the Formosan Medical Association (2021) Vol. 121, Iss. 1, pp. 58-65
Open Access | Times Cited: 2
THE ROLE OF A SPECIALIST PHARMACIST IN THE MANAGEMENT OF ADALIMUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Johannes Hegner, Janki Patel, Steven Fong, et al.
International Journal of Pharmacy and Pharmaceutical Sciences (2021), pp. 30-33
Open Access | Times Cited: 2
Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model
Anthony J. McKenzie, Brie N. Noble, Megan C. Herink, et al.
Journal of Pharmacy Practice (2023) Vol. 37, Iss. 3, pp. 637-643
Closed Access
Erkrankungen von Leber und Pankreas
Hans‐Peter Kapfhammer
Springer eBooks (2022), pp. 475-542
Closed Access
Assessment and Management of the Dermatological Side Effects of Direct-Acting Antiviral Agent Groups Used in the Treatment of Hepatitis C: A Prospective Study
Şenay Ağırgöl, Muharrem Agirgol
Medical Bulletin of Haseki (2021) Vol. 59, Iss. 3, pp. 239-244
Open Access
Page 1

Scroll to top